We are investigating GoHealth, Inc. (GOCO) (“GoHealth” or the “Company”) for potential violations of the federal securities laws. On or about July 15, 2020, GoHealth conducted its initial public offering (“IPO”), selling approximately 43,500,000 shares of its Class A common stock priced at $21.00 per share. Then, on August 19, 2020, in its first quarterly earnings report following the IPO, GoHealth announced it incurred a net loss of $22.9 million after posting net income of $15.3 million in the prior-year period. On this news, the Company’s stock price fell $1.99 per share, or 10.46%, to close at $17.03 per share on August 20, 2020, representing a 18.90% decline from the IPO price.